Thromboplastin time, INR reporting and recommendations for anticoagulant therapy
Syrjälä, M.
Duodecim; Laaketieteellinen Aikakauskirja 110(2): 171-172
1994
ISSN/ISBN: 0012-7183 PMID: 7555788 Document Number: 433900
Document emailed within 1 workday
Related Documents
Lämmle, B.; Furlan, M.; Sulzer, I. 1989: Comparison of a sensitive rabbit brain thromboplastin and a human placenta thromboplastin for thromboplastin time determination Schweizerische Medizinische Wochenschrift 119(6): 178-183Thomson, J.M.; Chart, I.S. 1970: The system for laboratory control of oral anticoagulant therapy using the British comparative thromboplastin Journal of Medical Laboratory Technology 27(2): 207-212
Barthels, M.; Bruhn, H.D.; Duckert, F.; Meyer, J.G.; Dati, F.; Fuhge, P. 1987: Determination of thromboplastin time with a new standardized thromboplastin from human placenta: results of a cooperative study Journal of Clinical Chemistry and Clinical Biochemistry 25(4): 267-280
Shimazu, C.; Fukuda, T. 2004: Activated partial thromboplastin time (APTT), partial thromboplastin time (PTT) Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 12): 590-593
Hashizume, K.; Kawai, K.; Kane, N.; Fukuda, R.; Matsubara, F. 1973: Studies on determination of partial thromboplastin time and prothrombin time using BBL fibrometer Rinsho Byori. Japanese Journal of Clinical Pathology 21(8): 721-724
Keshgegian, A.A.; Mann, J.M.; Cooper, J.H. 1986: Is duplicate testing for prothrombin time and activated partial thromboplastin time necessary? Archives of Pathology and Laboratory Medicine 110(6): 520-522
Langer, B.; Fuess, V.L.; Kauffman, P.; Bechara, M.J.; dos Reis, J.M.; Kwang, W.T. 1984: Comparison between the dilution curves of prothrombin time and activated partial thromboplastin time for the control of the effect of anti-vitamin K Revista do Hospital das Clinicas 39(1): 18-22
Reisenbichler, E.S.; Lester, S.C.; Richardson, A.L.; Dillon, D.A.; Ly, A.; Brock, J.E. 2013: Interobserver concordance in implementing the 2010 ASCO/CAP recommendations for reporting ER in breast carcinomas: a demonstration of the difficulties of consistently reporting low levels of ER expression by manual quantification American Journal of Clinical Pathology 140(4): 487-494
Barbe, D.; Bauduer, F.; Tanguy, A. 1991: Prothrombin time, activated partial thromboplastin time, plasma fibrinogen determination. Comparison of two automated coagulation systems: Koagulab 40-A and ACL-100 Annales de Biologie Clinique 49(10): 507-513
Jespersen, J.; Hansen, M.S.; Dyerberg, J.; Ingerslev, J.; Jensen, G.; Jørgensen, M.; Laursen, B.; Nielsen, J.D.; Svendsen, T.L. 1991: Standardized prothrombin time determinations and optimal anticoagulant therapy Ugeskrift for Laeger 153(5): 355-360
Van den Besselaar, A.M.; Loeliger, E.A. 1985: Massive hyperanticoagulation following the therapeutic recommendations of a thromboplastin retailer Deutsche Medizinische Wochenschrift 110(23): 937-938
van den Besselaar, A.M. 1990: Recommended method for reporting therapeutic control of oral anticoagulant therapy. Control of Anticoagulation Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis Thrombosis and Haemostasis 63(2): 316-317
Omoregie, R.; Osakue, S.I.; Ihemeje, V.; Omokaro, E.U.; Ogeferet, H.O. 2009: Correlation of CD4 count with platelet count, prothrombin time and activated partial thromboplastin time among HIV patients in Benin City, Nigeria West Indian Medical Journal 58(5): 437-440
Palareti, G. 1996: Anticoagulant therapy in patients with atrial fibrillation: the experience of the Centers of Surveillance. Study group of the "Italian Study on Complications of Oral Anticoagulant Therapy" (ISCOAT) Annali Italiani di Medicina Interna: Organo Ufficiale Della Societa Italiana di Medicina Interna 11(Suppl 2): 18s-20s
Werlberger, B.; Weiger, G. 1978: A practical method for the determination of thromboplastin time Tierarztliche Praxis 6(1): 119-123
Vargas, V.; Croxato, M.; Ossandon, A. 1970: Partial thromboplastin time as a screening test in hemorrhagic diseases Revista Medica de Chile 98(10): 679-681
Hoffmann, J.J.; Meulendijk, P.N. 1978: Comparison of reagents for determining the activated partial thromboplastin time Thrombosis and Haemostasis 39(3): 640-645
Tripodi, A.; Chantarangkul, V.; Arbini, A.A.; Moia, M.; Mannucci, P.M. 1993: Effects of hirudin on activated partial thromboplastin time determined with ten different reagents Thrombosis and Haemostasis 70(2): 286-288
Fitzmaurice, D.A.; Hobbs, F.D. 1996: Evaluation of a primary care anticoagulant clinic. Reporting of results should be standardised Bmj 312(7046): 1609-1610
McCullagh, M.; McArt, S. 2011: Learning through incident reporting: time to consider a national incident reporting system Irish Medical Journal 104(9): 261